What is InnoGenomics Technologies?
InnoGenomics Technologies, LLC is a specialized provider of advanced DNA extraction and analysis systems. Their product portfolio includes the SpermX Differential Extraction System for efficient sperm cell capture and male DNA profiling, the InnoTyper 21 DNA typing system, and the InnoQuant HY assay for sensitive human and male DNA assessment. The company also offers custom biological samples and laboratory services, primarily serving forensic laboratories engaged in sexual assault investigations and other critical forensic analyses. InnoGenomics is dedicated to advancing the precision and speed of DNA testing within the forensic field.
How much funding has InnoGenomics Technologies raised?
InnoGenomics Technologies has raised a total of $84K across 1 funding round:
Debt
$84K
Debt (2021): $84K with participation from PPP
Key Investors in InnoGenomics Technologies
PPP
Public-Private Partnership
What's next for InnoGenomics Technologies?
With the recent substantial expansion capital, InnoGenomics Technologies is poised to further enhance its product development and market reach. The significant Series B/C stage funding suggests a strategic focus on scaling operations, potentially expanding its technological capabilities, and solidifying its position as a key player in the forensic DNA analysis market. Future investments will likely target the refinement of existing systems and the introduction of new analytical tools to meet the evolving demands of forensic science.
See full InnoGenomics Technologies company page
